Hindustantimes wants to start sending you push notifications. Click allow to subscribe
[

favipiravir

]

Favipiravir helps in mild to moderate Covid-19 cases, reduces treatment time: Study

Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co at Fujifilm's headquarters in Tokyo.
Updated on Nov 21, 2020 07:48 PM IST

Combination of antiviral drugs shows ‘no superior outcome’ for Covid treatment: Firm

The FAITH study enrolled a total of 158 hospitalised patients with moderate symptoms of Covid-19 in India.
Published on Oct 10, 2020 10:04 AM IST

Odisha issues SOP for use of antiviral drug Favipiravir by Covid-19 patients

Favipiravir is not recommended for children and pregnant women.
Updated on Oct 03, 2020 11:56 PM IST

Fusion Health Care launches COVID-19 drug Favipiravir and an immunity booster

Mr. Madhu Ramadugu, Managing Director, Fusion Health Care.
Updated on Aug 17, 2020 05:17 PM IST

Favipiravir quickens recovery, show trials

A lab technician wearing a full-face mask and a protective suit holds tablets of investigational coronavirus disease (Covid-19) treatment drug Favipiravir.
Updated on Jul 23, 2020 01:04 AM IST

Glenmark Pharma drops price of Covid-19 drug Favipiravir to Rs 75/tablet

The antiviral oral drug is marketed under the brand name FabiFlu and was formally launched in the country on June 21.
Updated on Jul 13, 2020 09:28 PM IST

Glenmark gets India approval for favipiravir as Covid-19 treatment

Shares of Glenmark Pharmaceuticals closed at Rs 409.10 per scrip on the BSE, up 0.93 per cent from its previous close.
Published on Jun 19, 2020 08:25 PM IST

Glenmark to study efficacy of two antiviral drugs for treating Covid-19

Finished tablets sit inside an unsealed container during the manufacture of the Favipiravir antiviral medicine at a plant in Khimki, Russia.
Updated on May 26, 2020 05:36 PM IST

Glenmark begins phase 3 clinical trials of favipiravir

Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first company in the country to do so, in Mumbai on Tuesday.
Updated on May 13, 2020 04:58 AM IST

Coronavirus: China says Japanese anti-flu agent Favipiravir effective on Covid-19 patients

Covid-19 patients who were given Favipiravir reported quicker recovery with greater signs of lung improvement.
Updated on Mar 19, 2020 12:10 PM IST
This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.